LumiMeds review

What it is

LumiMeds is the trading name of Luminate Ventures LLC, based at 1810 East Sahara Avenue in Las Vegas, Nevada. It describes itself as a patient-management platform rather than a medical practice or pharmacy: the clinicians who review intakes and prescribe are independent, and its terms name Telegra MD LLC as an affiliated provider group. Medication comes from third-party pharmacy partners, which its product pages describe as state-licensed 503A compounding pharmacies for the GLP-1s and an FDA-registered 503B outsourcing pharmacy, Olympia, for NAD⁺. The site names Dr. Teresa Walsh, M.D., as medical director, describing her as board-certified in obesity medicine. It says it has served more than 50,000 patients. Beyond weight loss, it sells compounded NAD⁺ as a longevity plan. It's self-pay only and doesn't submit insurance claims, but it accepts HSA and FSA cards and offers Klarna payment plans. The care team answers portal messages and phone calls weekdays from 7 a.m. to 7 p.m. Pacific and weekends from 8 a.m. to 4 p.m.

How it works

You start with an online quiz the site says takes about two minutes, pick a plan, then complete a medical intake. A licensed provider reviews it, asynchronously or by a live visit depending on your state's rules, and the FAQ says it aims to have a doctor review within 24 hours. Patients generally need a BMI of 25 or more, though each case is reviewed individually, and if you're already on a GLP-1 elsewhere you may be able to continue at your current dose. If you're prescribed, medication ships in temperature-controlled packaging; the site says most orders ship within two business days of approval and arrive in three to five. From there, a care coordinator and your provider handle check-ins, dose changes and refills through the patient portal, which is open around the clock for messages.

Pricing transparency

The weight-loss pages advertise compounded semaglutide "as low as $39 first month" and tirzepatide from $75 for the first month, with monthly, 3-, 6- and 12-month plans available; a site banner was offering $50 off the longer plans. LumiMeds says the price is flat across doses and that there's no membership fee, with the provider evaluation, medication, shipping and check-ins included. The month-to-month price after the first month isn't shown on the public pages; you see it when you choose a plan during sign-up, so check it before paying. The membership terms are firm. Each plan is a fixed-term commitment, payable up front or in installments, and you owe the full term once it starts, with no early termination, refund or proration. Cancellation requests other than a prescription denial carry a non-refundable $100 fee, an order can't be canceled once it reaches the pharmacy, and shipped medication can't be returned. LumiMeds can change plan prices with 28 days' notice. You're refunded in full if a provider decides treatment isn't right for you.

Branded vs compounded

Providers prescribe compounded semaglutide or compounded tirzepatide as once-weekly injections from a multi-dose vial with syringes. The site states that compounded medications are not FDA-approved and haven't been evaluated by the FDA for safety or effectiveness, and that they aren't brand-name or generic drugs. Brand-name Wegovy, Ozempic, Zepbound and Mounjaro aren't offered as plans. In September 2025 the FDA sent LumiMeds a warning letter after reviewing its website in August 2025. The agency objected to claims that its compounded semaglutide and tirzepatide had "the same active ingredient as the brand name medications" and to wording that implied FDA approval, and said those claims made the products misbranded. LumiMeds shows a LegitScript badge that links to LegitScript's search page rather than to a numbered certification, so check its status on LegitScript's site. NAD⁺ is sold separately as a once-monthly injection.

Pros and watch-outs

The evidence behind what LumiMeds prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How LumiMeds compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Direct Meds

  Straightforward compounded GLP-1 without an insurance requirement

  See Direct Meds →
• Strut Health

  A general telehealth that covers GLP-1 alongside other everyday care

  See Strut Health →
• Kova

  People who want a compounded GLP-1 with an app that keeps them on top of doses, protein and side effects

  See Kova →

More GLP-1 telehealth reviews: Corsica Health · Cost Plus Drugs · CVS MinuteClinic · Framework · Freya Meds · FuturHealth